These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6128713)

  • 1. Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. I. Parenteral administration.
    Jonkman JH; Wijsbeek J; De Zeeuw RA; Van Bork LE; Orie NG; Soeterboek AM; Bender J
    Pharm Weekbl Sci; 1982 Oct; 4(5):122-8. PubMed ID: 6128713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and excretion of the quaternary ammonium compound thiazinamium methylsulfate (Multergan) in man. II. Oral and rectal administration.
    Jonkman JH; Wijsbeek J; De Zeeuw RA; Van Bork LE; Orie NG
    Pharm Weekbl Sci; 1982 Oct; 4(5):129-34. PubMed ID: 6128714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic disposition and biliary excretion of the organic cations thiazinamium and thiazinamium sulfoxide in rats.
    Neef K; Jonkman JH; Meijer DK
    J Pharm Sci; 1978 Aug; 67(8):1147-50. PubMed ID: 671255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variations in the bioavailability of thiazinamium methylsulfate.
    Jonkman JH; Van Bork LE; Wijsbeek J; De Zeeuw RK; Orie NG
    Clin Pharmacol Ther; 1977 Apr; 21(4):457-63. PubMed ID: 849677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proceedings: Bioavailability of the quaternary ammonium compound thiazinamium methylsulphate (Multergan) after oral and intramuscular administration.
    Jonkman JH; Wijsbeek U; Brouwer SH; De Zeeuw RA
    J Pharm Pharmacol; 1974 Dec; 26 Suppl():63P. PubMed ID: 4156742
    [No Abstract]   [Full Text] [Related]  

  • 6. First-pass effect after rectal administration of thiazinamium methylsulfate.
    Jonkman JH; van Bork LE; Wijsbeek J; Bolhuis-de Vries AS; de Zeeuw RA; Orie NG; Cox HL
    J Pharm Sci; 1979 Jan; 68(1):69-72. PubMed ID: 758468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic first-pass effect of thiazinamium methylsulfate (N-methylpromethazine methylsulfate) in dogs.
    Jonkman JH; Westenberg HG; Van Der Kleyn E
    J Pharm Sci; 1981 Aug; 70(8):947-9. PubMed ID: 6118426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of intramuscular thiazinamium methyl sulfate.
    Jonkman JH; Van Bork LE; Calvert B; Greving JE; Wijsbeek J; De Zeeuw RA; Orie NG
    Int J Clin Pharmacol Ther Toxicol; 1983 Sep; 21(9):454-9. PubMed ID: 6138313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of low cencentrations of the quaternary ammonium compound thiazinamium methylsulphate in plasma and urine.
    Jonkman JG; Wijsbeek J; Hollenbeek S; de Boer SH; de Zeeuw RA; Van Bork LE; Orie NG
    J Pharm Pharmacol; 1975 Nov; 27(11):849-54. PubMed ID: 1494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole body distribution of the quaternary ammonium compound thiazinamium (N-methylpromethazine) and promethazine in monkey and mice.
    Jonkman JH; Westenberg HG; Rijntjes NV; van der Kleijn E; Lindeboom SF
    Arzneimittelforschung; 1983; 33(2):223-8. PubMed ID: 6133524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of thiazinamium in asthmatic patients.
    Holford NH; Clements P; Collier P; Orie NG; van Bork LE; Jonkman JH
    Eur J Clin Pharmacol; 1987; 33(3):237-42. PubMed ID: 2891535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "First pass effect" after rectal administration of thiazinamium methylsulphate [proceedings].
    Jonkman JH; van Bork LE; Wijsbeek J; de Zeeuw RA; Orie NG; Cox HL
    J Pharm Pharmacol; 1976 Dec; 28 Suppl():56P. PubMed ID: 12333
    [No Abstract]   [Full Text] [Related]  

  • 13. Initial nociceptive sensitization in carrageenin-induced rat paw inflammation is dependent on amine autacoid mechanisms: electrophysiological and behavioural evidence obtained with a quaternary antihistamine, thiazinamium.
    Neil A; Benoist JM; Kayser V; Guilbaud G
    Exp Brain Res; 1987; 65(2):343-51. PubMed ID: 2881800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of "irreversible" airway obstruction by thiazinamium (Multergan).
    Bouhuys A; Ortega J
    Pneumonologie; 1976 Jun; 153(3):185-95. PubMed ID: 785411
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of thiazinamium chloride, promethazine and chlorpromazine on thromboxane B2 synthesis, phagocytosis and respiratory burst by rat alveolar macrophages.
    Chang J; Piperata S; Skowronek M; Lewis AJ
    Biochem Pharmacol; 1983 Sep; 32(18):2671-7. PubMed ID: 6138040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability after intramuscular injection.
    Jonkman JH; van Bork LE; de Zeeuw RA; Orie NG
    Lancet; 1976 Mar; 1(7961):693. PubMed ID: 73664
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular weight as a factor in the excretion of monoquaternary ammonium cations in the bile of the rat, rabbit and guinea pig.
    Hughes RD; Millburn P; Williams RT
    Biochem J; 1973 Dec; 136(4):967-78. PubMed ID: 4786541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination pathways of terbutaline.
    Tegnér K; Nilsson HT; Persson CG; Persson K; Ryrfeldt A
    Eur J Respir Dis Suppl; 1984; 134():93-100. PubMed ID: 6586491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of intramuscular administration of thiazinamium and inhaled histamine on forced inspiratory volume in 1 s.
    Gimeno F; van Altena R
    Respiration; 1993; 60(4):227-31. PubMed ID: 7903469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic and therapeutic use of thiazinamium (Multergan)].
    van Bork LE; Jonkman JH; de Zeeuw RA; Orie NG; Peset R; de Vries K
    Ned Tijdschr Geneeskd; 1977 Jul; 121(30):1196-202. PubMed ID: 887179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.